Patents by Inventor Laurie A. Kenvin

Laurie A. Kenvin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY FOR TREATING MALIGNANCIES
    Publication number: 20210100805
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH2 mutation using a combination of an inhibitor of a mutant IDH2 enzyme and a DNA demethylating agent.
    Type: Application
    Filed: May 21, 2020
    Publication date: April 8, 2021
    Inventors: Vivek Saroj Kumar Chopra, Jorge DiMartino, Laurie A. Kenvin, Robert Douglas Knight, Kyle MacBerth, Krishnan Viswanadhan, Qiang Xu, Samuel V. Agresta
  • Combination therapy for treating malignancies
    Patent number: 10695352
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH2 mutation using a combination of an inhibitor of a mutant IDH2 enzyme and a DNA demethylating agent.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: June 30, 2020
    Assignees: Celgene Corporation, Agios Pharmaceuticals, Inc.
    Inventors: Vivek Saroj Kumar Chopra, Jorge DiMartino, Laurie A. Kenvin, Robert Douglas Knight, Kyle MacBeth, Krishnan Viswanadhan, Qiang Xu, Samuel V. Agresta
  • COMBINATION THERAPY FOR TREATING MALIGNANCIES
    Publication number: 20180303840
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH2 mutation using a combination of an inhibitor of a mutant IDH2 enzyme and a DNA demethylating agent.
    Type: Application
    Filed: October 14, 2016
    Publication date: October 25, 2018
    Inventors: Vivek Saroj Kumar Chopra, Jorge DiMartino, Laurie A. Kenvin, Robert Douglas Knight, Kyle MacBeth, Krishnan Viswanadhan, Qiang Xu, Samuel V. Agresta